ImageneBio Inc (IMA) Financials

IMA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 136.7 million 13.4 million
Dec. 31, 2025 153.0 million 19.8 million
Sept. 30, 2025 160.9 million 21.0 million
June 30, 2025 126.2 million 10.3 million

IMA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -14.8 million 876000
Dec. 31, 2025 -7.2 million 51000
Sept. 30, 2025 -26.6 million 14.0 million
June 30, 2025 -3.4 million 458000

IMA Net Income

No data available :(

IMA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 117.2 million 5.7 million 110000
Dec. 31, 2025 75.8 million 7.0 million 3.0 million
Sept. 30, 2025 142.6 million 7.5 million 3.4 million
June 30, 2025 95.6 million - 5.7 million

IMA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 11.2 million
Dec. 31, 2025 11.2 million
Sept. 30, 2025 8.5 million
June 30, 2025 48.3 million

IMA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 6.0 million 6.1 million -
Dec. 31, 2025 - 5.2 million -370000 -
Sept. 30, 2025 - 15.6 million 11.0 million -
June 30, 2025 - 4.0 million 4.4 million -

IMA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 174000
Dec. 31, 2025 - 561000
Sept. 30, 2025 - -
June 30, 2025 - 45000

IMA

Price: $6

52 week price:
3.94
18.00

Earnings Per Share: -4.78 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 64.2 million

Links: